GeneTether Therapeutics Inc. Aktie - Unternehmensdaten & Kurse - CA37187D1087 | goSPATZ

GeneTether Therapeutics Inc.

Share · CA37187D1087 (XCNQ)

No Price

n/a

Share Float & Liquidity

Free Float 22,49 %

Shares Float 8,71 M

Shares Outstanding 38,74 M

Company Profile for GeneTether Therapeutics Inc. Share

GeneTether Therapeutics Inc., a genetic medicines company, focuses on developing gene editing therapies to enhance the efficiency of genome editing technologies. It is developing gene therapies for the treatment of patients with rare and monogenic kidney and skin diseases. The company was founded in 2018 and is based in Kelowna, Canada.

Get up to date insights from finAgent about GeneTether Therapeutics Inc.

Company Data

Name GeneTether Therapeutics Inc.

Company GeneTether Therapeutics Inc.

Website https://genetether.com

Primary Exchange

CSE LISTED

ISIN CA37187D1087

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Roland Boivin

Country Canada

Currency CAD

Employees -

Address 301 – 1665 Ellis Street, V1Y 2B3 Kelowna

IPO Date 2022-03-30

Ticker Symbols

Name	Symbol
Over The Counter	GNTTF
CSE LISTED	GTTX.CN

More Shares

Investors who hold GeneTether Therapeutics Inc. also have the following shares in their portfolio:

HANETF-FD DE.SC DLA ETF

LGT CP SUS.STR.3YRS EO B Fund

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025